Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Operating Leases (2022 - 2025)

NeuroPace has reported Operating Leases over the past 4 years, most recently at $9.8 million for Q4 2025.

  • Quarterly results put Operating Leases at $9.8 million for Q4 2025, down 17.71% from a year ago — trailing twelve months through Dec 2025 was $9.8 million (down 17.71% YoY), and the annual figure for FY2025 was $9.8 million, down 17.71%.
  • Operating Leases for Q4 2025 was $9.8 million at NeuroPace, down from $12.4 million in the prior quarter.
  • Over the last five years, Operating Leases for NPCE hit a ceiling of $15.7 million in Q3 2022 and a floor of $3.2 million in Q2 2022.
  • Median Operating Leases over the past 4 years was $13.6 million (2023), compared with a mean of $12.3 million.
  • Biggest five-year swings in Operating Leases: skyrocketed 354.36% in 2023 and later dropped 25.45% in 2025.
  • NeuroPace's Operating Leases stood at $15.4 million in 2022, then dropped by 10.53% to $13.8 million in 2023, then fell by 13.47% to $12.0 million in 2024, then decreased by 17.71% to $9.8 million in 2025.
  • The last three reported values for Operating Leases were $9.8 million (Q4 2025), $12.4 million (Q3 2025), and $10.9 million (Q2 2025) per Business Quant data.